Sylvie N’Gbeche

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

Michael Schomaker, Valériane Leroy, Tom F.W. Wolfs et al. · International Journal of Epidemiology · 2016 · 47 citations · Full text

Public Health, Child Health, Pediatrics +15

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation

Sophie Desmonde, François Tanoh Eboua, Karen Malateste et al. · AIDS · 2015 · 23 citations · Full text

Public Health, Child Health, Pediatrics +16

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years

Michael Schomaker, Mary‐Ann Davies, Karen Malateste et al. · Epidemiology · 2015 · 18 citations · Full text

Public Health, Child Health, Pediatrics +17

Virological response and resistances over 12 months among HIV‐infected children less than two years receiving first‐line lopinavir/ritonavir‐based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort

Clarisse Amani‐Bosse, Désiré Lucien Dahourou, Karen Malateste et al. · Journal of the International AIDS Society · 2017 · 18 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial

Désiré Lucien Dahourou, Madeleine Amorissani‐Folquet, Karen Malateste et al. · BMC Medicine · 2017 · 17 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16